Impact of heated tobacco products on biomarkers of potential harm and adverse events: a systematic review and meta-analysis
Tobacco Control · 2026
DOI: 10.1136/tc-2024-059000 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Tobacco Control, 2026. Verfasst von Sophie Braznell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tobacco Control Research Group, Department for Health, University of Bath, Bath, UK seb91@bath.ac.uk. Hauptthemen laut MEDLINE: Tobacco Products, Hot Temperature. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bloomberg Philanthropies.
Themen: Patientensicherheit
Abstract (Originalsprache)
Objective
To systematically review available data on the effects of heated tobacco products (HTPs) on biomarkers of potential harm (BoPH) and adverse events, including comparison to cigarettes, e-cigarettes and smoking abstinence. Data sources Web of Science, Scopus, MedRxiv, ClinicalTrials.gov, ICTRP database and HTP manufacturer libraries were searched from January 2010 to December 2024. Study selection Included studies were interventional clinical trials of any design that measured BoPH or adverse events in adults assigned a marketed HTP and another assigned either cigarettes, e-cigarettes or smoking abstinence. Data extraction Two reviewers independently extracted data into a predesigned form and assessed risk of bias using Cochranes Risk of Bias tool version 1. Data synthesis BoPH data were synthesised using effect direction plots. A random-effects model was used to calculate pooled risk ratios for adverse event data. 40 studies (10 independent, 29 industry-affiliated and 1 of unclear affiliation) were included. Only nine studies lasted longer than 5 days. 19 involved using the intervention just once. Risk of bias was high for 32 studies and unclear for 8. Data on 143 BoPH indicated short-term HTP use had mixed effects compared with cigarettes, e-cigarettes and smoking abstinence. The rate of adverse event reporting was not significantly different between HTP and any comparator group.
Conclusions
Despite a growing evidence base, significant limitations hinder interpretation of the data, which do not yet provide clear indication of harm or benefit, even compared with cigarettes. Longer, better quality studies independent of tobacco industry funding are needed to determine the health impacts of HTPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tobacco Control Research Group, Department for Health, University of Bath, Bath, UK seb91@bath.ac.uk.
- Department of Psychology, University of Bath, Bath, UK.
- Department of Health Promotion and Policy, University of Massachusetts Amherst, Amherst, Massachusetts, USA.
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
- Tobacco Control Research Group, Department for Health, University of Bath, Bath, UK.
- Centre for 21st Century Public Health, Department for Health, University of Bath, Bath, UK.
ORCID-Profile: Sophie Braznell, Sarah Dance
Förderung
- Bloomberg Philanthropies
Zitieren
APA
Braznell, S., Dance, S., Hartmann-Boyce, J., & Gilmore, A. (2026). Impact of heated tobacco products on biomarkers of potential harm and adverse events: a systematic review and meta-analysis. Tobacco Control. https://doi.org/10.1136/tc-2024-059000
Vancouver
Braznell S, Dance S, Hartmann-Boyce J, Gilmore A. Impact of heated tobacco products on biomarkers of potential harm and adverse events: a systematic review and meta-analysis. Tobacco Control. 2026. doi:10.1136/tc-2024-059000
BibTeX
@article{Braznell2026,
author = {Braznell, Sophie and Dance, Sarah and Hartmann-Boyce, Jamie and Gilmore, Anna},
title = {Impact of heated tobacco products on biomarkers of potential harm and adverse events: a systematic review and meta-analysis},
journal = {Tobacco Control},
year = {2026},
doi = {10.1136/tc-2024-059000}
}
EUVIMED